Science 37 Holdings Inc (SNCE) Gross Profit Margin starting from the third quarter 2023 to third quarter 2022, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Science 37 Holdings Inc   (NASDAQ: SNCE)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Science 37 Holdings Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SNCE Gross Profit Margin (Sep 30 2023)
Q3 		(Jun 30 2023)
Q2 		(Mar 31 2023)
Q1 		(Dec 31 2022)
Q4 		(Sep 30 2022)
Q3
Y / Y Revenue Change -8.38 %
Seq. Revenue Change -3.02 %
Revenue In Millions $14.89
Gross Profit Margin 39.73 %
Gross Profit Margin Total Ranking # 2257
Gross Profit In Millions $5.92
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting Third Quarter 2023 Gross Profit Margin
Science 37 Holdings Inc achieved Gross Profit of $6 millions compare to Gross Loss of $0.00 millions booked in the previous quarter. Despite the sequential Revenue deterioration in Q3 of -3.02 % Science 37 Holdings Inc managed to reduce Cost of Sales and turn into profitability by achieving a Gross Profit of 6 compare to Gross Loss of $0.00 millions realized in the previous quarter. Company accomplished Gross Profit Margin of 39.73 %, a new company high.


Observing third quarter 2023 results within Medical Laboratories industry 21 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 2257.
Learn about Gross Margin
SNCE's Gross Profit Margin third quarter 2023 Company Ranking
Within: No.
Medical Laboratories Industry # 22
Healthcare Sector # 395
Overall # 2227

Gross Profit Margin Statistics
High Average Low
39.73 % 27.46 % 14.45 %
(Sep 30 2023)   (Mar 31 2022)


SNCE Gross Income Trends • More of SNCE's Profitabilty Ratios • SNCE Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
SNCE's Cumulative Gross Profit Margin
Medical Laboratories Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
SNCE's Gross Profit Margin Profitability versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for SNCE's Competitors
Gross Profit Margin Profit Margin for Science 37 Holdings Inc 's Suppliers
Gross Profit Margin Profit Margin for SNCE's Customers

You may also want to know
SNCE's Annual Growth Rates SNCE's Profitability Ratios SNCE's Asset Turnover Ratio SNCE's Dividend Growth
SNCE's Roe SNCE's Valuation Ratios SNCE's Financial Strength Ratios SNCE's Gross Profit Growth
SNCE's Roa SNCE's Inventory Turnover Ratio SNCE's Growth Rates SNCE's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2023, within Medical Laboratories Industry Gross Profit MarginSep 30 2023 MRQ Gross ProfitSep 30 2023 MRQ Revenue
Incyte Corporation  93.46 %$ 858.934  Millions$ 919.025  Millions
Maxcyte inc   90.09 %$ 7.211  Millions$ 8.005  Millions
Castle Biosciences Inc   81.59 %$ 50.174  Millions$ 61.493  Millions
Caredx Inc   80.33 %$ 53.975  Millions$ 67.192  Millions
Veracyte Inc   75.78 %$ 68.281  Millions$ 90.108  Millions
Bioaffinity Technologies Inc   74.97 %$ 0.224  Millions$ 0.298  Millions
Exact Sciences Corporation  73.27 %$ 461.877  Millions$ 630.403  Millions
Inotiv Inc   70.88 %$ 99.751  Millions$ 140.740  Millions
Nrc Health  61.44 %$ 23.312  Millions$ 37.945  Millions
Butterfly Network Inc   60.99 %$ 9.382  Millions$ 15.382  Millions
Luna Innovations Inc  57.56 %$ 17.629  Millions$ 30.629  Millions
Exagen Inc   57.44 %$ 7.706  Millions$ 13.416  Millions
Somalogic Inc   54.67 %$ 12.054  Millions$ 22.048  Millions
Hologic Inc  52.92 %$ 500.300  Millions$ 945.300  Millions
Ispecimen inc   49.87 %$ 1.385  Millions$ 2.778  Millions
Ge Healthcare Technologies Inc   48.24 %$ 1,935.000  Millions$ 4,011.000  Millions
Fulgent Genetics Inc   47.52 %$ 39.844  Millions$ 83.844  Millions
Natera Inc   45.23 %$ 121.344  Millions$ 268.306  Millions
Charles River Laboratories International inc   42.77 %$ 439.063  Millions$ 1,026.623  Millions
American Shared Hospital Services  41.20 %$ 2.102  Millions$ 5.102  Millions
Psychemedics Corporation  41.07 %$ 2.091  Millions$ 5.091  Millions
Science 37 Holdings Inc   39.73 %$ 5.915  Millions$ 14.887  Millions
Iqvia Holdings Inc   35.06 %$ 1,310.000  Millions$ 3,736.000  Millions
Quest Diagnostics Inc  32.85 %$ 754.000  Millions$ 2,295.000  Millions
Invitae Corporation  32.21 %$ 39.055  Millions$ 121.241  Millions
Labcorp Holdings Inc   27.85 %$ 851.200  Millions$ 3,056.800  Millions
Medpace Holdings Inc   27.04 %$ 133.193  Millions$ 492.499  Millions
Personalis Inc   19.08 %$ 3.481  Millions$ 18.247  Millions
Fortrea Holdings Inc   16.63 %$ 129.100  Millions$ 776.400  Millions
Bionexus Gene Lab Corp   13.88 %$ 0.354  Millions$ 2.554  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.